Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemoglobin

Showing results (1231-1240 of 2,379) with videos related to

Pageof 238
Sort By:
Hemoglobin|May 1, 1996
Hb Aubenas [beta 62(B8)Glu-->Gly]: a new variant normally synthesized, affecting the same codon as in Hb EP Lacan, A Francina, D Promé, et al.
Hemoglobin|May 14, 2008
Molecular spectrum of beta-thalassemia mutations in Northwestern IranMohammad A Hosseinpour Feizi, Abbas A Hosseinpour Feizi, Nasser Pouladi, et al.
Hemoglobin|May 14, 2008
An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry)Béatrice Gulbis, Alice Ferster, Christiane Vermylen, et al.
Hemoglobin|May 14, 2008
Frameshift mutation in the alpha2-globin gene causing alpha+ -thalassemia: codon 49 (-GC)Barry Eng, John S Waye
Hemoglobin|October 10, 2009
Update on thalassemia treatment in Taiwan, including bone marrow transplantation, chelation therapy, and cardiomyopathy treatment effectsChing-Tien Peng, Jeng-Sheng Chang, Lin-Yen Wang, et al.
Hemoglobin|October 10, 2009
A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patientsGeorge J Kontoghiorghes
Hemoglobin|October 10, 2009
Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patientsGodfrey Chi-Fung Chan, Shing Chan, Pak-Leung Ho, et al.
Hemoglobin|October 10, 2009
Risk/benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditionsGeorge J Kontoghiorghes, Aglaia Efstathiou, Marios Kleanthous, et al.
Hemoglobin|April 25, 2025
Heterozygous Beta Thalassemia with Segmental Duplication of chr16p13.3 Leading to Thalassemia Intermedia Phenotype: A Report of 2 Cases with Review of LiteratureEkta Jajodia, Neeraj Arora, Moquitul Haque, et al.
Hemoglobin|March 31, 2025
Prevalence and Molecular Characteristics of Hemoglobin Variants in Laibin City, Central Guangxi of Southern ChinaYuan-Yuan Huang, Li-Hua Ye, Wei Li, et al.
Pageof 238

Showing results (1231-1240 of 2,379) with videos related to

Sort By:
Pageof 238
Hemoglobin|May 1, 1996
Hb Aubenas [beta 62(B8)Glu-->Gly]: a new variant normally synthesized, affecting the same codon as in Hb EP Lacan, A Francina, D Promé, et al.
Hemoglobin|May 14, 2008
Molecular spectrum of beta-thalassemia mutations in Northwestern IranMohammad A Hosseinpour Feizi, Abbas A Hosseinpour Feizi, Nasser Pouladi, et al.
Hemoglobin|May 14, 2008
An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry)Béatrice Gulbis, Alice Ferster, Christiane Vermylen, et al.
Hemoglobin|May 14, 2008
Frameshift mutation in the alpha2-globin gene causing alpha+ -thalassemia: codon 49 (-GC)Barry Eng, John S Waye
Hemoglobin|October 10, 2009
Update on thalassemia treatment in Taiwan, including bone marrow transplantation, chelation therapy, and cardiomyopathy treatment effectsChing-Tien Peng, Jeng-Sheng Chang, Lin-Yen Wang, et al.
Hemoglobin|October 10, 2009
A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patientsGeorge J Kontoghiorghes
Hemoglobin|October 10, 2009
Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patientsGodfrey Chi-Fung Chan, Shing Chan, Pak-Leung Ho, et al.
Hemoglobin|October 10, 2009
Risk/benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditionsGeorge J Kontoghiorghes, Aglaia Efstathiou, Marios Kleanthous, et al.
Hemoglobin|April 25, 2025
Heterozygous Beta Thalassemia with Segmental Duplication of chr16p13.3 Leading to Thalassemia Intermedia Phenotype: A Report of 2 Cases with Review of LiteratureEkta Jajodia, Neeraj Arora, Moquitul Haque, et al.
Hemoglobin|March 31, 2025
Prevalence and Molecular Characteristics of Hemoglobin Variants in Laibin City, Central Guangxi of Southern ChinaYuan-Yuan Huang, Li-Hua Ye, Wei Li, et al.
Pageof 238